Clinical Trial Update: Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating futibatinib in combination with durvalumab prior to cystectomy for patients with muscle-invasive bladder cancer ineligible for cisplati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer
• Stage Iiia Bladder Cancer
• Urothelial Carcinoma of the Bladder

Drugs mentioned

• Durvalumab (durvalumab)
• Futibatinib (futibatinib)

Snippet

Sponsor: Yuanquan Yang | Conditions: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma | Phase 2 | Status: RECRUITING